Skip to main content
logo
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.5330
-0.0130 (-2.38%)
At close: Aug 12, 2026, 4:00 PM EDT
0.5500
+0.0170 (3.19%)
After-hours: Aug 12, 2026, 4:02 PM EDT

Mangoceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
913186--
Market Cap Growth
-57.69%-24.43%195.53%---
Enterprise Value
9.412.0617.675.3200
Last Close Price
0.530.742.424.15--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
22.6129.0228.448.10--
PB Ratio
0.690.871.307.65--
P/TBV Ratio
-7.70-5.75--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
22.9026.4428.697.27--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0200.010.080.48-
Net Debt / Equity Ratio
0.01-0.080.01-0.79-0.54-
Net Debt / EBITDA Ratio
-0.010.07-0.020.070.17-
Net Debt / FCF Ratio
-0.020.20-0.030.090.24-
Asset Turnover
0.030.030.080.710.02-
Inventory Turnover
--25.5032.43--
Quick Ratio
0.261.690.043.502.62-
Current Ratio
0.291.740.053.962.67-
Return on Equity (ROE)
-133.97%-141.66%-118.31%-1326.69%-650.80%-
Return on Assets (ROA)
-106.78%-121.77%-105.88%-897.62%-397.01%-
Return on Invested Capital (ROIC)
-111.90%-126.19%-110.12%-2270.73%-747.50%-
Return on Capital Employed (ROCE)
-112.80%-131.45%-117.60%-1165.16%-536.30%-

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-377.17%-408.93%-84.23%-49.22%-34.98%-
Total Shareholder Return
-377.17%-408.93%-84.23%-49.22%-34.98%-
SEC Filings: 10-K · 10-Q